The depth and breadth of research at Mass General to cure brain disease is extraordinary. From cell-based research into disease causation, to the assessment of those cell-based changes in transgenic animal models, to clinical trials involving human patients — we are doing everything possible to help our patients. A particular strength of the programs at Mass General is that many of our scientific investigators are also physicians who are treating patients impacted by the diseases they are studying.

Join us on Wednesday, Oct. 30 for Path to a Cure: MIND 2013 Research Symposium for scientific presentations featuring:

The path to a cure for neurodegenerative diseaseMerit Cudkowicz, MD
Chief of Neurology